SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3KM'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BCU_H_PRLH280_0 (ALPHA-THROMBIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 6 / 9 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | 3KM A 900 (-2.9A)3KM A 900 (-3.6A)NoneNone3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.32A | 1bcuH-4r0iA:37.3 | 1bcuH-4r0iA:35.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DWC_H_MITH1_1 (ALPHA-THROMBIN(LARGE SUBUNIT)) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 5 / 9 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 226 | 3KM A 900 ( 4.4A)3KM A 900 (-2.9A)3KM A 900 (-3.6A)None3KM A 900 (-3.2A) | 0.42A | 1dwcH-4r0iA:36.4 | 1dwcH-4r0iA:35.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ETR_H_MITH1_1 (EPSILON-THROMBIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 7 / 12 | HIS A 57ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | 3KM A 900 ( 4.4A)3KM A 900 (-2.9A)3KM A 900 (-3.6A)NoneNone3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.50A | 1etrH-4r0iA:36.1 | 1etrH-4r0iA:35.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1F5L_A_AMRA301_1 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 7 / 8 | ASP A 189SER A 190GLN A 192SER A 195VAL A 213GLY A 216GLY A 226 | 3KM A 900 (-2.9A)3KM A 900 (-2.9A)None3KM A 900 (-3.6A)None3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.40A | 1f5lA-4r0iA:36.7 | 1f5lA-4r0iA:33.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GXS_A_BEZA601_0 (P-(S)-HYDROXYMANDELONITRILE LYASE CHAINAP-(S)-HYDROXYMANDELONITRILE LYASE CHAINB) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 4 / 7 | GLY A 216ASP A 102HIS A 57ALA A 55 | 3KM A 900 (-3.4A)None3KM A 900 ( 4.4A)None | 0.98A | 1gxsA-4r0iA:undetectable1gxsB-4r0iA:undetectable | 1gxsA-4r0iA:21.151gxsB-4r0iA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQP_B_SAMB500_1 (5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 4 / 8 | ASP A 102PHE A 94SER A 195ALA A 104 | NoneNone3KM A 900 (-3.6A)None | 1.14A | 1rqpC-4r0iA:undetectable | 1rqpC-4r0iA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQP_C_SAMC500_0 (5'-FLUORO-5'-DEOXYADENOSINE SYNTHASE) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 4 / 8 | ASP A 102PHE A 94SER A 195ALA A 104 | NoneNone3KM A 900 (-3.6A)None | 1.12A | 1rqpA-4r0iA:undetectable | 1rqpA-4r0iA:20.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TNL_A_TPAA900_1 (TRYPSIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 6 / 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | 3KM A 900 (-2.9A)3KM A 900 (-2.9A)3KM A 900 (-3.6A)None3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.22A | 1tnlA-4r0iA:37.5 | 1tnlA-4r0iA:39.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 6 / 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | 3KM A 900 (-2.9A)3KM A 900 (-2.9A)3KM A 900 (-3.6A)None3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.15A | 2otvA-4r0iA:37.6 | 2otvA-4r0iA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2P16_A_GG2A298_1 (COAGULATION FACTOR X(EC 3.4.21.6)(STUART FACTOR)(STUART-PROWERFACTOR)) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 7 / 12 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 226TYR A 228 | 3KM A 900 (-2.9A)3KM A 900 (-3.6A)NoneNone3KM A 900 (-3.4A)3KM A 900 (-3.2A)None | 0.28A | 2p16A-4r0iA:36.8 | 2p16A-4r0iA:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QO6_A_CHDA130_0 (LIVER-BASIC FATTYACID BINDING PROTEIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 5 / 12 | LEU A 106ILE A 88LEU A 85VAL A 31HIS A 57 | NoneNoneNoneNone3KM A 900 ( 4.4A) | 1.31A | 2qo6A-4r0iA:undetectable | 2qo6A-4r0iA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2V7U_A_SAMA1299_0 (5'-FLUORO-5'-DEOXYADENOSINE SYNTHETASE) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 4 / 8 | ASP A 102PHE A 94SER A 195ALA A 104 | NoneNone3KM A 900 (-3.6A)None | 1.13A | 2v7uA-4r0iA:undetectable | 2v7uA-4r0iA:20.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W26_A_RIVA1001_1 (ACTIVATED FACTOR XAHEAVY CHAIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 8 / 12 | ASP A 189SER A 195VAL A 213TRP A 215GLY A 216GLY A 219GLY A 226TYR A 228 | 3KM A 900 (-2.9A)3KM A 900 (-3.6A)NoneNone3KM A 900 (-3.4A)3KM A 900 (-3.9A)3KM A 900 (-3.2A)None | 0.32A | 2w26A-4r0iA:36.9 | 2w26A-4r0iA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GY3_A_PNTA246_0 (CATIONIC TRYPSIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 8 / 11 | HIS A 57GLN A 175ASP A 189SER A 190SER A 195TRP A 215GLY A 216GLY A 226 | 3KM A 900 ( 4.4A)None3KM A 900 (-2.9A)3KM A 900 (-2.9A)3KM A 900 (-3.6A)None3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.50A | 3gy3A-4r0iA:37.2 | 3gy3A-4r0iA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RXF_A_4APA9_1 (CATIONIC TRYPSIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 6 / 6 | SER A 190SER A 195VAL A 213TRP A 215GLY A 216GLY A 226 | 3KM A 900 (-2.9A)3KM A 900 (-3.6A)NoneNone3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.24A | 3rxfA-4r0iA:15.1 | 3rxfA-4r0iA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RXH_A_HSMA7_1 (CATIONIC TRYPSIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 5 / 5 | ASP A 189SER A 190SER A 195VAL A 213GLY A 226 | 3KM A 900 (-2.9A)3KM A 900 (-2.9A)3KM A 900 (-3.6A)None3KM A 900 (-3.2A) | 0.23A | 3rxhA-4r0iA:37.7 | 3rxhA-4r0iA:40.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FU8_A_ACTA302_0 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 4 / 5 | HIS A 57GLN A 192GLY A 193SER A 195 | 3KM A 900 ( 4.4A)NoneNone3KM A 900 (-3.6A) | 0.26A | 4fu8A-4r0iA:37.0 | 4fu8A-4r0iA:33.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HFP_D_15UD402_1 (PROTHROMBIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 5 / 12 | HIS A 57ASP A 189VAL A 213TRP A 215GLY A 226 | 3KM A 900 ( 4.4A)3KM A 900 (-2.9A)NoneNone3KM A 900 (-3.2A) | 0.36A | 4hfpD-4r0iA:36.0 | 4hfpD-4r0iA:35.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 5 / 12 | HIS A 57VAL A 213TRP A 215GLY A 216GLY A 226 | 3KM A 900 ( 4.4A)NoneNone3KM A 900 (-3.4A)3KM A 900 (-3.2A) | 0.35A | 4rn6B-4r0iA:30.4 | 4rn6B-4r0iA:31.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MUG_A_VIVA301_1 (ALPHA-TOCOPHEROLTRANSFER PROTEIN) |
4r0i | SUPPRESSOR OFTUMORIGENICITY 14PROTEIN (Homosapiens) | 3 / 3 | SER A 214SER A 195PHE A 94 | None3KM A 900 (-3.6A)None | 0.92A | 5mugA-4r0iA:undetectable | 5mugA-4r0iA:19.60 |